Consequently, because ZIKV and DENV do not efficiently antagonize type I interferon (IFN) signaling in mice as they would do in humans, animals were treated with a single dose of blocking monoclonal antibody against mouse IFNAR1 to facilitate ZIKV infection and dissemination [48]. This evidence concerns the gene IFNA1 and Zika virus infectious disease.